Gate Square “Creator Certification Incentive Program” — Recruiting Outstanding Creators!
Join now, share quality content, and compete for over $10,000 in monthly rewards.
How to Apply:
1️⃣ Open the App → Tap [Square] at the bottom → Click your [avatar] in the top right.
2️⃣ Tap [Get Certified], submit your application, and wait for approval.
Apply Now: https://www.gate.com/questionnaire/7159
Token rewards, exclusive Gate merch, and traffic exposure await you!
Details: https://www.gate.com/announcements/article/47889
The Year in XRP 2025: New Highs After 7 Years as Ripple's SEC Case Finally Ends
Ripple had a busy 2025, highlighted by acquisitions, the end of a years-long court battle, and a burst to new heights for XRP.
In brief
Ripple Labs ended a yearslong court battle with the SEC in 2025, giving way to new growth for the firm.
That helped fuel the Ripple-linked XRP's surge to a new all-time high of $3.65.
The firm's stablecoin also blossomed to more than a $1 billion market cap, and it made four major acquisitions, helping its valuation grow to $40 billion.
Crypto’s biggest wins are often tightly connected to the rise in asset prices, but Ripple’s 2025 successes extend far beyond the price of XRP—the Ripple-linked asset that sits inside the top five crypto assets by market capitalization.
Instead, most of the biggest headlines attached to the financial services organization were irrelevant to trading screens, most notably the conclusion to its years-long battle with the SEC,
major acquisitions to propel its future growth, and the launch of a billion-dollar stablecoin product—RLUSD.
Below we’ll look back at the biggest highlights for XRP and Ripple in
Ripple, SEC saga comes to an end
More than four years after it began, the legal dispute between Ripple Labs Inc. and the U.S. Securities and Exchange Commission (SEC) officially came to a close in August.
The landmark case, which investigated whether or not sales of XRP violated securities laws, extended back to December 2020. In 2023, a partial ruling favored Ripple Labs, but appeals and counter-appeals extended the saga into 2025.